Stay updated on Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Sign up to get notified when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.

Latest updates to the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page
- Check7 days agoChange DetectedThe study record page gained new navigation items: How to Read a Study Record, Common Questions, and How to Join a Study, and it now shows a recruitment status of No longer looking for participants. The labeling of the Intervention/Treatment section was updated from Intervention / Treatment to Intervention/Treatment.SummaryDifference0.3%

- Check14 days agoChange DetectedThe page now shows Revision: v3.5.5, indicating an updated build of the study record. This change is a backend revision tag rather than a modification to the study details.SummaryDifference0.0%

- Check21 days agoNo Change Detected
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating an update to the page's version of the study record.SummaryDifference0.0%

- Check57 days agoChange DetectedUpdates the displayed ClinicalTrials.gov page revision from **v3.5.2** to **v3.5.3**.SummaryDifference0.0%

- Check64 days agoChange DetectedAdded Ono Pharmaceutical Co., Ltd. and Revision: v3.5.2; removed Ono Pharmaceutical Co. Ltd and Revision: v3.5.0.SummaryDifference0.1%

- Check79 days agoChange DetectedLocation entry for Italy 35128 updated from Padua to Padova. Padova, Italy, 35128 is now listed as a site.SummaryDifference0.0%

Stay in the know with updates to Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Investigator's Choice in Head and Neck Cancer Clinical Trial page.